Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Thalassemia × Busulfan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 126 Myelodysplastic Syndromes 99 Leukemia 98 Precursor Cell Lymphoblastic Leukemia-Lymphoma 82 Lymphoma 77 Lymphoma, Non-Hodgkin 71 Multiple Myeloma 63 Hodgkin Disease 58 Leukemia, Lymphocytic, Chronic, B-Cell 51 Lymphoma, Large B-Cell, Diffuse 43 Myeloproliferative Disorders 42 Leukemia, Myeloid, Accelerated Phase 41 Leukemia, Myeloid, Chronic-Phase 40 Neoplasms, Plasma Cell 39 Leukemia, Myelomonocytic, Chronic 39 Congenital Abnormalities 39 Lymphoma, Follicular 38 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 36 Lymphoma, Mantle-Cell 35 Burkitt Lymphoma 35 Blast Crisis 34 Lymphoma, B-Cell, Marginal Zone 33 Lymphoma, Large-Cell, Immunoblastic 32 Recurrence 30 Primary Myelofibrosis 29 Hematologic Neoplasms 29 Myelodysplastic-Myeloproliferative Diseases 28 Anemia, Refractory, with Excess of Blasts 27 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 26 Graft vs Host Disease 26

Interventions

fludarabine 4 fludarabine phosphate 3 Cyclophosphamide 3 thymoglobulin 1 Whole-Body Irradiation 1 Thiotepa 1 Tacrolimus 1 Rituximab 1 Peripheral Blood Stem Cell Transplantation 1 Mycophenolic Acid 1 Mesna 1 Melphalan 1 Erythrocyte Count 1 Dexamethasone 1 Clofarabine 1 Busulfan 1 Bortezomib 1 Blood Transfusion 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00578292 2020-05-01

THALLO

Baylor College of Medicine

Phase NA Terminated

10 enrolled 15 charts

Lymphoma, Follicular, Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡